The problem with drug patents is that they end, leading to patent cliffs. That's when cheaper generic versions of a drug take ...

When you look past what artificial intelligence can do, which is truly incredible, you see that it is just a fancy computer ...

Altria has an attractive 7.4% dividend yield backed by a growing dividend, but there is more for investors to consider.

The New Year's Champagne turned flat for Madrigal Pharmaceuticals ( MDGL 5.01%) on Tuesday. Investors traded out of the ...

Meanwhile, the company continues to send a lot of cash back to shareholders. In fiscal 2025, Visa returned $22.8 billion ...

Let's return to our initial question: Should you buy stocks if a recession is coming in 2026? If history is an guide, the ...

BYD has already proven it can scale. In 2026, the real test is whether it can turn that scale into durable profits.

One of the main occupants of the assisted/autonomous driving domain is, of course, Tesla. The company has leaned heavily into ...

On Jan. 6, 2026, a $1.5 billion stock sale, bearish rating, and bullish options bets put this fintech in sharp focus.

Today, Jan. 6, 2026, institutional buying and a focus on AI-related machine growth helped the nickel miner's shares.

On Jan. 6, 2026, investors weighed Grab’s AI-fueled delivery push against fresh growth, margin, and funding signals.

2025 is finally over, and it's an exciting time for technology investors as they ride the wave of new megatrends like ...